ClinConnect ClinConnect Logo
Search / Trial NCT06662214

Nutrient Profile and Muscle Protein Synthesis in Response to Corn Bread Made From Refined Versus Whole Grain Maize Flour

Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Oct 25, 2024

Trial Information

Current as of October 22, 2025

Recruiting

Keywords

Muscle Protein Synthesis Post Prandial Nutrient And Hormonal Profile Farming Practices

ClinConnect Summary

This clinical trial is studying how different types of corn bread—made from whole grain maize flour and refined maize flour—affect the body after eating, especially in relation to muscle health. Participants will enjoy a traditional East African meal that includes mung bean stew and one of the two types of corn bread, and researchers will look at how the body reacts in terms of nutrients, hormones, and muscle protein production.

To take part, you need to be a healthy adult aged 18 to 30 who is physically active, meaning you exercise at least 150 minutes per week. You should also have a normal weight. Unfortunately, if you have certain health issues, dietary restrictions, or allergies to corn, you wouldn't be eligible. During the trial, participants can expect to eat the meals provided and help researchers learn more about how our food choices impact muscle health. This is an exciting opportunity to contribute to important nutrition research!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Healthy active males and females (To be considered active, volunteers must meet the following American College of Sports Medicine's guideline for physical activity for healthy adults: performing at least 150 minutes per week of moderate-to-vigorous intensity physical activity.
  • Age18-30 years
  • Normal weight (BMI between 18 and 25 kg/m2
  • Exclusion Criteria:
  • Health or dietary restrictions that would prevent consumption of the test foods
  • Known food allergy to corn
  • Anemia (low red blood cell count)
  • Overweight or obesity (BMI \> 25 kg/m2)
  • Receiving any medication that may interfere with the study
  • Metabolic or endocrine disorder that would affect the digestion, absorption, and/or physiological response to any of the nutrients ingested.
  • Currently not meeting the ACSM physical activity recommendations (IPAQ score \< 150 min/week of moderate-to-vigorous physical activity.
  • Pregnancy

About University Of California, Davis

The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.

Locations

Sacramento, California, United States

Patients applied

0 patients applied

Trial Officials

Keith Baar

Principal Investigator

University of California, Davis

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported